EP2418210A1 — Thiophene-carboxamides useful as inhibitors of protein kinases
Assigned to Vertex Pharmaceuticals Inc · Expires 2012-02-15 · 14y expired
What this patent protects
The present invention relates to compounds of formula I useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various diseases, conditions, o…
USPTO Abstract
The present invention relates to compounds of formula I useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various diseases, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Drugs covered by this patent
- Copiktra (DUVELISIB) · Secura
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.